Company news
Ainos, Inc. (NASDAQ:AIMD) news
Ainos, Inc. news releases on 6ix. Latest, May 12, 2023: Ainos Reports First Quarter 2023 Financial Results
Press releases — page 3
Ainos Reports First Quarter 2023 Financial Results
May 11, 2023
Ainos Reports Fourth Quarter and Full Year 2022 Financial Results
March 30, 2023
Ainos Signs Agreement Establishing Topmed as Exclusive Distributor of VELDONA Animal Health Supplements in Taiwan
March 20, 2023
Ainos and Merdury Sign MoU to Explore Phase 3 Study of VELDONA Drug Candidate for Treatment of Oral Warts in HIV-Seropositive Patients
March 13, 2023
Ainos Announces US$3 Million Convertible Notes Private Placement
March 12, 2023
Ainos and Tah-An Sign MoU to Explore Manufacture of VELDONA Animal Investigational New Drug
January 22, 2023
Ainos Issues 2023 Shareholder Letter
January 16, 2023
Ainos Reports Unaudited Third Quarter 2022 Financial Results
November 6, 2022
Ainos Announces Positive Results from Additional Preclinical Study of Its Low-dose Oral Interferon Formulation Against New Variant Virus - Omicron
September 29, 2022
Ainos Submits Investigational New Drug Application to the U.S. FDA to Conduct Phase 2 Trial of its VELDONA Low-dose Oral Interferon Formulation Against Mild COVID-19 Symptoms
August 23, 2022
Ainos Announces Master Services Agreement with Swiss Pharmaceutical, Ltd. for Drug Testing, Manufacturing, and Packaging for its VELDONA Product Candidates
August 16, 2022
Ainos Reports Second Quarter 2022 Financial Results
August 14, 2022
Ainos Announces Closing of $3.3 Million Public Offering, Uplisting to NASDAQ, and Reverse Stock Split
August 10, 2022
Ainos Announces Pricing of $3.3 Million Public Offering, Uplisting to NASDAQ, and Reverse Stock Split
August 7, 2022
Ainos Announces Positive Results from Preclinical Studies of Its Low-dose Oral Interferon Formulation Against COVID-19
June 26, 2022
Ainos COVID-19 Antigen Self-Test Receives Approval for Sale in Taiwan
June 20, 2022
Ainos Announces Strategic Relationship with InnoPharmax to Jointly Develop Combined Oral Therapy for Coronavirus Infection
December 6, 2021
Ainos Elects Ms. Hui-Lan (Celia) Wu as CFO, Lawrence K. Lin as Executive Vice President of Operations, and Other Key Executives
August 15, 2021
Ainos Named Exclusive Sales Partner for COVID-19 Antigen Rapid Test Kit in Taiwan
June 14, 2021